| Ankur Drugs & Pharma has reported a sales turnover of Rs 35.51 crore and a net loss of Rs 23.47 crore for the quarter ended Sep '12. | | For the quarter ended Sep 2011 the sales turnover was Rs 33.47 crore and net loss was Rs 30.86 crore. |
|
| | Quarterly Results of Ankur Drugs & Pharma | -------- in Rs. Cr. -------- |
|
| Sep '11 | | | Jun '12 | Sep '12 | | Sales Turnover | 33.47 | | | 33.27 | 35.51 | | Other Income | 0.04 | | | 0.02 | 0.01 | | Total Income | 33.51 | | | 33.29 | 35.52 | | Total Expenses | 44.36 | | | 36.16 | 36.33 | | Operating Profit | -10.89 | | | -2.89 | -0.82 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | -10.85 | | | -2.87 | -0.81 | | Interest | 4.74 | | | 43.81 | 6.16 | | PBDT | -15.59 | | | -46.68 | -6.97 | | Depreciation | 15.27 | | | 16.81 | 16.50 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | -30.86 | | | -63.49 | -23.47 | | Tax | -- | | | -- | -- | | Net Profit | -30.86 | | | -63.49 | -23.47 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | -- | | | -- | -- | | Book Value | -- | | | -- | -- | | Equity | 19.34 | | | 19.34 | 19.34 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
